Clinical Trial Update: Study of Xuanbai Shengmai Decoction in the Treatment of Acute Respiratory Distress Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating Xuanbai Shengmai Decoction for Acute Respiratory Distress Syndrome; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Xuanbai Shengmai Decoction

Snippet

Sponsor: Southeast University, China | Conditions: Acute Respiratory Distress Syndrome (ARDS) | Phase 3 | Status: NOT_YET_RECRUITING